enrollment
-
Neuro
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States
Randomized controlled clinical trial expected to validate effectiveness of ReActiv8® Restorative NeurostimulationTM vs. optimal medical management DUBLIN, August 29, 2023–(BUSINESS WIRE)–Mainstay Medical…
Read More » -
Spine
Synergy Spine Solutions Announces First Patient Enrolled in the Synergy Disc® 2-Level IDE Trial
LOUISVILLE, Colo., June 29, 2023 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc…
Read More » -
Spine
Aurora Spine Announces Initial Patient Enrolled for DEXA-C™ Multicenter Study
Carlsbad, Calif, June 28, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a…
Read More » -
Biologics
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair – is marketed in over 35 countries outside the U.S. where it…
Read More » -
Spine
3Spine Announces 200 of 300 Patients Enrolled in Ongoing Studies
Open 3Spine MOTUS device (PRNewsfoto/3Spine) CHATTANOOGA, Tenn., March 30, 2023 /PRNewswire/ — 3Spine, Inc., today announced completion of the 50th MOTUS lumbar total joint…
Read More » -
Spine
Genesys Spine® Announces First Patients Enrolled in The SIros™ Lateral Sacroiliac Joint Fusion Study
AUSTIN, Texas, Oct. 21, 2022 /PRNewswire/ — Genesys Spine announced today the first two patients have been enrolled in the prospective SIros™ Lateral…
Read More » -
Sports Medicine
Ortho Regenerative Technologies Announces Enrollment of First Patient in its U.S. Phase l/ll Rotator Cuff Tear Repair Clinical Trial
First patient surgery completed; additional surgeries already scheduled8 clinical centres now fully initiated and recruiting / screening for patients MONTREAL, July…
Read More » -
Spine
InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study
Topline data expected to be reported in Q1 2023 June 2, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV),…
Read More » -
Spine
Karolinska Development’s portfolio company OssDsign completes patient enrollment to the TOP FUSION study
STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has enrolled…
Read More »